Imunon (IMNN) Assets Average (2011 - 2026)
Imunon's (IMNN) quarterly Assets Average came in at $10.2 million in Q1 2026, up 22.48% YoY from $8.3 million in Q1 2025, and down 4.55% on a QoQ basis from $10.6 million in Q4 2025.
Imunon (IMNN) Assets Average (2011 - 2026) Analysis & Trends
Imunon (IMNN) has 16 years of Assets Average data on file, last reported at $10.2 million in Q1 2026.
- Quarterly Assets Average rose 22.48% year-over-year to $10.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.2 million (up 22.48% YoY) and the FY2025 annual result came in at $11.0 million, down 30.44% from the prior year.
- Assets Average retreated to $10.2 million in Q1 2026, from $10.6 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $69.2 million in Q1 2022 to a low of $7.8 million in Q2 2025.
- A 5-year average of $30.2 million and a median of $23.3 million in 2023 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2022 — Assets Average rose 25.16% — and 2024, when it slumped 66.09%.
- Tracing IMNN's Assets Average over 5 years: stood at $52.3 million in 2022, then slumped by 55.44% to $23.3 million in 2023, then tumbled by 48.43% to $12.0 million in 2024, then fell by 11.41% to $10.6 million in 2025, then slipped by 4.55% to $10.2 million in 2026.
- The last three Assets Average figures came in at $10.2 million (Q1 2026), $10.6 million (Q4 2025), and $8.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.34 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.09 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.27 Bn |
| 10 | Imunon | 8.16 Mn | 8.16 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.15 Mn |
| Dec 31, 2025 | 10.64 Mn |
| Sep 30, 2025 | 8.89 Mn |
| Jun 30, 2025 | 7.83 Mn |
| Mar 31, 2025 | 8.29 Mn |
| Jun 30, 2024 | 12.01 Mn |
| Mar 31, 2024 | 18.12 Mn |
| Dec 31, 2023 | 23.29 Mn |
| Sep 30, 2023 | 26.69 Mn |
| Jun 30, 2023 | 35.41 Mn |
| Mar 31, 2023 | 43.04 Mn |
| Dec 31, 2022 | 52.25 Mn |
| Sep 30, 2022 | 62.93 Mn |
| Jun 30, 2022 | 64.83 Mn |
| Mar 31, 2022 | 69.19 Mn |
| Dec 31, 2021 | 76.76 Mn |
| Sep 30, 2021 | 81.24 Mn |
| Jun 30, 2021 | 78.03 Mn |
| Mar 31, 2021 | 55.28 Mn |
| Dec 31, 2020 | 37.40 Mn |